320 related articles for article (PubMed ID: 20466686)
1. Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
Catapano F; Chaudhry AN; Jones RB; Smith KG; Jayne DW
Nephrol Dial Transplant; 2010 Nov; 25(11):3586-92. PubMed ID: 20466686
[TBL] [Abstract][Full Text] [Related]
2. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
[TBL] [Abstract][Full Text] [Related]
4. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in the treatment of bullous systemic lupus erythematosus.
Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
[TBL] [Abstract][Full Text] [Related]
6. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
[TBL] [Abstract][Full Text] [Related]
7. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
8. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus.
Ng KP; Leandro MJ; Edwards JC; Ehrenstein MR; Cambridge G; Isenberg DA
Ann Rheum Dis; 2006 Jul; 65(7):942-5. PubMed ID: 16269424
[TBL] [Abstract][Full Text] [Related]
9. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
[TBL] [Abstract][Full Text] [Related]
11. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
Fernández-Nebro A; de la Fuente JL; Carreño L; Izquierdo MG; Tomero E; Rúa-Figueroa I; Hernández-Cruz BE; Narváez J; Ucar E; Olivé A; Zea A; Fernández-Castro M; Raya-Álvarez E; Pego-Reigosa JM; Freire M; Martínez-Taboada VM; Pérez-Venegas J; Sánchez-Atrio AI; Villa-Blanco I; Manrique-Arija S; López-Longo FJ; Carreira PE; Martínez-Pérez R; García-Vicuña R
Lupus; 2012 Sep; 21(10):1063-76. PubMed ID: 22786985
[TBL] [Abstract][Full Text] [Related]
12. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
[TBL] [Abstract][Full Text] [Related]
14. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
15. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab.
Hoyer BF; Mumtaz IM; Loddenkemper K; Bruns A; Sengler C; Hermann KG; Maza S; Keitzer R; Burmester GR; Buttgereit F; Radbruch A; Hiepe F
Ann Rheum Dis; 2012 Jan; 71(1):75-9. PubMed ID: 21953334
[TBL] [Abstract][Full Text] [Related]
16. B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response.
Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Ann Rheum Dis; 2007 Sep; 66(9):1259-62. PubMed ID: 17412738
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of recurrent pancreatitis secondary to systemic lupus erythematosus with B-cell depletion therapy.
Al-Musawi ZS; Nabar UJ
Arch Iran Med; 2011 Jan; 14(1):66-70. PubMed ID: 21194267
[TBL] [Abstract][Full Text] [Related]
18. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
[TBL] [Abstract][Full Text] [Related]
19. [Rituximab in systemic lupus erythematosus. Part I. Theoretical basis].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):131-4. PubMed ID: 20842829
[TBL] [Abstract][Full Text] [Related]
20. Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.
Iwata S; Saito K; Tokunaga M; Tanaka Y
Lupus; 2013 Apr; 22(5):538-40. PubMed ID: 23423251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
